Daré Bioscience Selected As A Member Of ARPA-H Investor Catalyst Hub Spoke Network
Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women's health innovation, today announced it was selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health
BenzingaMay 2 08:10 ET
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of H&E Equipment Services, Inc. (NASDAQ:HEES) fell sharply during Tuesday's session following mixed first-quarter results.H&E Equipment posted GAAP earnings of 71 cents per share, versus market
BenzingaApr 30 13:24 ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersAkili (NASDAQ:AKLI) stock moved upwards by 70.1% to $0.4 during Tuesday's regular session. The company's market cap stands at $31.4 million. Cyclacel Pharmaceuticals (NASDAQ:CYCC) stock rose 51
BenzingaApr 30 12:31 ET
Express News | Dare Bioscience Shares Are Trading Higher After the XOMA Acquired an Economic Interest in the Company's Women's Health Assets. Also, the Company Announced That the Transaction Allows It to Focus on Advancing Phase 3 First-in-category Women's Health Produc
BenzingaApr 30 07:47 ET
Xoma Has Acquired An Economic Interest In Three Women's Health Assets From Daré Bioscience For An Upfront Payment Of $22M
Organon, a global women's healthcare company, initiated XACIATO commercial activities in the fourth quarter of 2023.XOMA further expands its late-stage portfolio with synthetic royalty and milestone i
BenzingaApr 30 07:36 ET
Express News | Daré Bioscience Secures $22 Million in Non-Dilutive Strategic Royalty Financing to Advance Phase 3 First-in-Category Women’s Health Product Candidates Through Key Catalysts
ReutersApr 30 07:30 ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersAcrivon Therapeutics (NASDAQ:ACRV) stock rose 12.3% to $10.67 during Wednesday's after-market session. The market value of their outstanding shares is at $329.4 million. Amarin Corp (NASDAQ:AMR
BenzingaApr 24 16:31 ET
Express News | Daré Bioscience To Receive $1M Installment Under Grant To Advance Development Of DARE-LARC1
Moomoo 24/7Apr 23 08:08 ET
Express News | Dare Bioscience: Under Terms of Grant Agreement, Daré May Get up to About $49 Mln to Support Nonclinical Development of Dare-Larc1
Moomoo 24/7Apr 23 08:07 ET
Express News | Dare Bioscience: To Get $1 Mln as Latest Installment Under Grant Deal to Advance Development of Daré's Investigational Contraceptive Dare-Larc1
Moomoo 24/7Apr 23 08:06 ET
Press Release: Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1
Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1 Dare Bioscience's DARE-LARC1 Platform Technology has Transformative Po
Dow JonesApr 23 08:00 ET
Express News | Dare Bioscience Shares Are Trading Lower After Brookline Capital Downgraded the Stock From Buy to Hold
Moomoo 24/7Apr 17 13:31 ET
Express News | Brookline Capital Downgrades Dare Bioscience to Hold
Moomoo 24/7Apr 17 13:28 ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersINVO Bioscience (NASDAQ:INVO) stock rose 275.0% to $2.85 during Wednesday's regular session. The market value of their outstanding shares is at $7.4 million. As per the news, the Q4 earnings re
BenzingaApr 17 12:31 ET
Daré Bioscience Announces Publication In Contraception Of Efficacy And Safety Findings From A Pre-Pivotal Postcoital Test Study Of Ovaprene: An Investigational Hormone-Free Monthly Intravaginal Contraceptive
Published data shows that Ovaprene was safe and effective in a postcoital test study of 33 womenPivotal Phase 3 contraceptive efficacy clinical study of Ovaprene currently enrollingOvaprene has the po
BenzingaApr 11 08:15 ET
Express News | HC Wainwright & Co. Reiterates Buy on Dare Bioscience, Maintains $6 Price Target
Moomoo 24/7Apr 1 06:06 ET
Dare Bioscience Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/01/2024 1059.42% HC Wainwright & Co. → $6 Reiterates Buy → Buy 11/10/2023 1059.42% HC Wainwright & Co.
BenzingaApr 1 06:05 ET
Q4 2023 Dare Bioscience Inc Earnings Call
Yahoo FinanceMar 29 09:07 ET
Earnings Call Summary | Dare Bioscience(DARE.US) Q4 2023 Earnings Conference
The following is a summary of the Daré Bioscience, Inc. (DARE) Q4 2023 Earnings Call Transcript:Financial Performance:Daré Bioscience recorded total revenue of about $2.8 million in 2023, anchored b
moomoo AIMar 28 21:07 ET · Conference Call
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersQilian Intl Hldg Gr (NASDAQ:QLI) shares increased by 73.2% to $1.1 during Thursday's after-market session. The company's market cap stands at $39.3 million. Sunshine Biopharma (NASDAQ:SBFM) sha
BenzingaMar 28 16:31 ET
No Data
No Data